135 related articles for article (PubMed ID: 24375257)
61. Clinicopathologic features and prognosis of primary gastrointestinal stromal tumor patients under 35 years of age: A 10-year retrospective study.
Zhang P; Deng R; Liu K; Shuai XM; Bai J; Chang WL; Gao JB; Cai KL; Wang GB; Tao KX
J Surg Oncol; 2016 Dec; 114(8):977-981. PubMed ID: 27664034
[TBL] [Abstract][Full Text] [Related]
62. Hepatic arterial embolization and chemoembolization for imatinib-resistant gastrointestinal stromal tumors.
Kobayashi K; Szklaruk J; Trent JC; Ensor J; Ahrar K; Wallace MJ; Madoff DC; Murthy R; Hicks ME; Gupta S
Am J Clin Oncol; 2009 Dec; 32(6):574-81. PubMed ID: 19636238
[TBL] [Abstract][Full Text] [Related]
63. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis.
Miettinen M; Lasota J
Arch Pathol Lab Med; 2006 Oct; 130(10):1466-78. PubMed ID: 17090188
[TBL] [Abstract][Full Text] [Related]
64. Gastrointestinal stromal tumors of the stomach in children and young adults: a clinicopathologic, immunohistochemical, and molecular genetic study of 44 cases with long-term follow-up and review of the literature.
Miettinen M; Lasota J; Sobin LH
Am J Surg Pathol; 2005 Oct; 29(10):1373-81. PubMed ID: 16160481
[TBL] [Abstract][Full Text] [Related]
65. Gastrointestinal stromal tumors: a 19 year experience.
Rabin I; Chikman B; Lavy R; Sandbank J; Maklakovsky M; Gold-Deutch R; Halpren Z; Wassermann I; Halevy A
Isr Med Assoc J; 2009 Feb; 11(2):98-102. PubMed ID: 19432038
[TBL] [Abstract][Full Text] [Related]
66. Factors affecting clinical outcomes in women with non-gastric gastrointestinal stromal tumors.
Huang PH; Chen YY; Chen HH; Ting WH; Lin HH; Chen KH; Hsiao SM
Taiwan J Obstet Gynecol; 2022 Mar; 61(2):306-311. PubMed ID: 35361392
[TBL] [Abstract][Full Text] [Related]
67. Clinicopathologic study of 275 cases of gastrointestinal stromal tumors: the experience at 3 large medical centers in Mexico.
Alvarado-Cabrero I; Vázquez G; Sierra Santiesteban FI; Hernández-Hernández DM; Pompa AZ
Ann Diagn Pathol; 2007 Feb; 11(1):39-45. PubMed ID: 17240306
[TBL] [Abstract][Full Text] [Related]
68. Conventional Risk Stratification Fails to Predict Progression of Succinate Dehydrogenase-deficient Gastrointestinal Stromal Tumors: A Clinicopathologic Study of 76 Cases.
Mason EF; Hornick JL
Am J Surg Pathol; 2016 Dec; 40(12):1616-1621. PubMed ID: 27340750
[TBL] [Abstract][Full Text] [Related]
69. Gastrointestinal stromal tumours (GISTs): a clinicopathological and molecular study of 66 cases.
Koay MH; Goh YW; Iacopetta B; Grieu F; Segal A; Sterrett GF; Platten M; Spagnolo DV
Pathology; 2005 Feb; 37(1):22-31. PubMed ID: 15875730
[TBL] [Abstract][Full Text] [Related]
70. Metastatic gastrointestinal stromal tumors in the era of imatinib: improved survival and elimination of socioeconomic survival disparities.
Artinyan A; Kim J; Soriano P; Chow W; Bhatia S; Ellenhorn JD
Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2194-201. PubMed ID: 18708414
[TBL] [Abstract][Full Text] [Related]
71. "Pediatric-type" gastrointestinal stromal tumors in adults: distinctive histology predicts genotype and clinical behavior.
Rege TA; Wagner AJ; Corless CL; Heinrich MC; Hornick JL
Am J Surg Pathol; 2011 Apr; 35(4):495-504. PubMed ID: 21358303
[TBL] [Abstract][Full Text] [Related]
72. Outcome following surgical therapy for gastrointestinal stromal tumors.
Gupta M; Sheppard BC; Corless CL; MacDonell KR; Blanke CD; Billingsley KG
J Gastrointest Surg; 2006; 10(8):1099-105. PubMed ID: 16966028
[TBL] [Abstract][Full Text] [Related]
73. Clinicopathological characteristics and prognosis of primary appendiceal stromal tumors.
Zhang B; Zheng GL; Zhu HT; Zhao Y; Zheng ZC
World J Surg Oncol; 2018 Nov; 16(1):225. PubMed ID: 30445975
[TBL] [Abstract][Full Text] [Related]
74. Gastrointestinal stromal tumors in a cohort of Chinese patients in Hong Kong.
Chan KH; Chan CW; Chow WH; Kwan WK; Kong CK; Mak KF; Leung MY; Lau LK
World J Gastroenterol; 2006 Apr; 12(14):2223-8. PubMed ID: 16610025
[TBL] [Abstract][Full Text] [Related]
75. Role and mechanism of vasculogenic mimicry in gastrointestinal stromal tumors.
Sun B; Qie S; Zhang S; Sun T; Zhao X; Gao S; Ni C; Wang X; Liu Y; Zhang L
Hum Pathol; 2008 Mar; 39(3):444-51. PubMed ID: 18261629
[TBL] [Abstract][Full Text] [Related]
76. Treatment and Prognoses in Patients With Primary Gastrointestinal Stromal Tumors ≥10 cm: A Single-Institution Experience in China.
Shen C; Chen H; Yin Y; Chen J; Tang S; Zhang B; Han L; Chen Z; Chen J
Medicine (Baltimore); 2015 Jul; 94(28):e1117. PubMed ID: 26181546
[TBL] [Abstract][Full Text] [Related]
77. Combination of PLR, MLR, MWR, and Tumor Size Could Significantly Increase the Prognostic Value for Gastrointestinal Stromal Tumors.
Feng F; Tian Y; Liu S; Zheng G; Liu Z; Xu G; Guo M; Lian X; Fan D; Zhang H
Medicine (Baltimore); 2016 Apr; 95(14):e3248. PubMed ID: 27057867
[TBL] [Abstract][Full Text] [Related]
78. S100A4 expression is associated with poor prognosis in patients with resectable gastrointestinal stromal tumor.
Shen W; Tan X; Hao F
Libyan J Med; 2019 Dec; 14(1):1659669. PubMed ID: 31474194
[TBL] [Abstract][Full Text] [Related]
79. Adjuvant therapy with imatinib mesylate after resection of primary high-risk gastrointestinal stromal tumors in Japanese patients.
Kanda T; Nishida T; Wada N; Kobayashi O; Yamamoto M; Sawaki A; Boku N; Koseki M; Doi T; Toh Y; Kakeji Y; Sugiyama T; Komatsu Y; Kikuchi S; Ogoshi K; Katai H; Miyachi K; Hirota S; Ohtsu A
Int J Clin Oncol; 2013 Feb; 18(1):38-45. PubMed ID: 22105894
[TBL] [Abstract][Full Text] [Related]
80. [Changes of diagnosis and treatment for gastrointestinal stromal tumors during a 18-year period in four medical centers of China].
Qiu H; Zhang P; Feng X; Chen T; Sun X; Yu J; Chen Z; Li Y; Tao K; Li G; Zhou Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1265-1270. PubMed ID: 27928797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
